Literature DB >> 33043060

A Systematic Review and Meta-analysis of Sex Differences in Morbidity and Mortality of Acute Lower Respiratory Tract Infections Among African Children.

Adebola E Orimadegun1, Adedayo A Adepoju2, Landon Myer3.   

Abstract

CONTEXT: Although biological sex influences Acute Lower Respiratory Tract Infections (ALRIs) morbidity and mortality patterns in children living in sub-Saharan Africa, the exact mechanism about the effect is unknown.
OBJECTIVE: We assessed the quality and strength of evidence on the association of sex with incidence, etiology, and outcomes of ALRI in African children. DATA SOURCES STUDY SELECTION AND DATA EXTRACTION: We systematically searched electronic databases for publications from 1971-2016 in PubMed, African Journals Online, and Google scholar for ALRI literature in the African children. We used (pneumonia OR bronchiolitis OR "community-acquired pneumonia" OR CAP OR "hospital-acquired pneumonia" OR "nosocomial pneumonia" OR "ventilator-acquired pneumonia" OR "lung abscess" OR "pleural effusion" OR "empyema thoracis") AND (sex OR gender) AND (Africa OR Sub-Saharan) as search terms. We included the published peer-reviewed journal articles reporting on incidence, etiology, and case fatality. We summarized the findings using narrative and meta-analysis methods.
RESULTS: We included 14 studies with sex-related data; the median (IQR) number of reported pneumonia cases was 148 (87-770) and 114 (56-599) for male and female patients, respectively. Only two studies reported a sex-specific incidence. The odds of sex were in favor of male sex, and the chances of identification of Respiratory Syncytia Virus (RSV) were significantly lower in males than in females (OR=0.60; 95% CI: 0.42, 0.86). Estimates from 9 studies showed that the death rate for males was significantly higher than for females (OR=1.26; 95% CI=1.20-1.33).
CONCLUSIONS: Sex-disaggregated data on incidence, etiology, and case fatality of pneumonia are scarcely reported in studies published in Africa. However, males appear to die more often than females, and females more likely to have RSV infection.

Entities:  

Keywords:  Pneumonia; Respiratory syncytial viruses; Respiratory tract infections; Sex characteristics

Year:  2020        PMID: 33043060      PMCID: PMC7544245          DOI: 10.32598/jpr.8.2.65

Source DB:  PubMed          Journal:  J Pediatr Rev        ISSN: 2322-4398


  40 in total

1.  Etiology and epidemiology of viral pneumonia among hospitalized children in rural Mozambique: a malaria endemic area with high prevalence of human immunodeficiency virus.

Authors:  Cristina O'Callaghan-Gordo; Quique Bassat; Luis Morais; Núria Díez-Padrisa; Sónia Machevo; Tacilta Nhampossa; Delino Nhalungo; Sergi Sanz; Llorenç Quintó; Pedro L Alonso; Anna Roca
Journal:  Pediatr Infect Dis J       Date:  2011-01       Impact factor: 2.129

2.  Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study.

Authors:  David M le Roux; Landon Myer; Mark P Nicol; Heather J Zar
Journal:  Lancet Glob Health       Date:  2015-02       Impact factor: 26.763

Review 3.  Respiratory syncytial virus infection in tropical and developing countries.

Authors:  M W Weber; E K Mulholland; B M Greenwood
Journal:  Trop Med Int Health       Date:  1998-04       Impact factor: 2.622

4.  Epidemiology and etiology of childhood pneumonia.

Authors:  Igor Rudan; Cynthia Boschi-Pinto; Zrinka Biloglav; Kim Mulholland; Harry Campbell
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

5.  The epidemiology of hospitalized pneumonia in rural Kenya: the potential of surveillance data in setting public health priorities.

Authors:  Jeffrey A Tornheim; Ayub S Manya; Norbert Oyando; Stewart Kabaka; Robert F Breiman; Daniel R Feikin
Journal:  Int J Infect Dis       Date:  2007-05-29       Impact factor: 3.623

6.  Host factors and acute lower respiratory infections in pre-school children.

Authors:  W B Johnson; W I Aderele; D A Gbadero
Journal:  J Trop Pediatr       Date:  1992-06       Impact factor: 1.165

7.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

8.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

9.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

10.  Variations in mortality in children admitted with pneumonia to Kenyan hospitals.

Authors:  Philip Ayieko; Emelda A Okiro; Tansy Edwards; Rachel Nyamai; Mike English
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

View more
  1 in total

1.  Sex-differences in incidence of hospitalizations and in hospital mortality of community-acquired pneumonia among children in Spain: a population-based study.

Authors:  Javier de-Miguel-Díez; Ana López-de-Andrés; Valentín Hernández-Barrera; José M de-Miguel-Yanes; David Carabantes-Alarcón; Zichen Ji; Jose J Zamorano-Leon; Rodrigo Jiménez-García
Journal:  Eur J Pediatr       Date:  2022-04-25       Impact factor: 3.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.